FDA Brief

Warning letters Drugs

FDA warning letter to

Belle Health LLC dba Belle

LowIssued Feb 20Posted Mar 3Center for Drug Evaluation and Research (CDER)

FDA warned Belle Health that its website falsely suggests Belle compounds semaglutide and tirzepatide, making the drugs misbranded.

What happened

In December 2025, FDA reviewed https://www.joinbelle.com and found it offered compounded semaglutide and tirzepatide drug products. The pictured labels show “Belle,” which FDA says falsely suggests Belle is the compounder when it is not. FDA calls the products misbranded, meaning their labeling is false or misleading.

What FDA found

  1. The website labels for compounded semaglutide and tirzepatide show “Belle,” which FDA says falsely suggests Belle is the compounder.

    FDCA § 502(a) [21 U.S.C. § 352(a)]; 21 CFR § 201.1(h)(2)
  2. FDA says Belle’s advertising or promotion of these compounded drugs is false or misleading.

    FDCA § 502(bb) [21 U.S.C. § 352(bb)]
  3. FDA says the misbranded drugs were introduced or delivered for introduction into interstate commerce.

    FDCA § 301(a) [21 U.S.C. § 331(a)]
  4. FDA also says receiving or delivering misbranded drugs in interstate commerce is prohibited.

    FDCA § 301(c) [21 U.S.C. § 331(c)]

What FDA wants

Within 15 working days, Belle must send FDA a written response describing steps taken to fix the violations, prevent recurrence, identify who makes the compounded products, provide sample labeling, and address or remove the misleading website claims.

Who should pay attention

  • telehealth companies selling compounded GLP-1 drugs
  • compounding pharmacies and their marketing partners
  • brands whose names appear on labels they do not manufacture

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low